GAS5 and neoplasm: The decreased expression of lncRNA GAS5 has been correlated with the clinical characteristics of the tumor, such as metastasis to the lymph nodes, tumor recurrence, decreased survival rates, and resistance to chemotherapy [9,10,11,12,13,14].